Updated on 4 September 2012
The Australian Government and state governments (such as Queensland) have continued to invest billions of dollars over the past decade to build and improve world class research and medical facilities and infrastructure. Many exciting and important initiatives have been established, bringing together world class centers in order to link translational health researchers, close infrastructure gaps, provide facilitated pathways for translational research in critical areas, support the funding of critical research and focus on international engagement.
Therapeutic Innovation Australia (TIA) was established in order to achieve these goals and increase the efficiency of Australian translational research. The TIA-Queensland Node is a consortium of five highly respected pre-clinical and clinical translational research centers with complementary expertise and experience.
The TIA-Queensland Node comprises of the following centers, including University of Queensland Center for Intergrated Preclinical Drug Development (CIPDD), University of Queensland Diamantina Institute, Griffith Health Institute (Griffith University), University of Queensland Center for Clinical Research-Center for Clinical Diagnostics, and the Queensland Clinical Trials and Biostatistics Center (University of Queensland). Australia's collaborative nature and eagerness to continually enhance the country's research capability and capacity, professionalism and international regard add to the country's appeal.
Australia plays home to a multitude of talented and respected local and international scientists, highly regarded research facilities and its universities are some of the highest-ranked in the world. Queensland in particular, has an international reputation for its clinical trial expertise including pre-clinical and early clinical phase development work, pharmacokinetics and pharmacogenomics.
State-of-the-art medical research facilities and hospitals, a globally active industry association like the LSQ, an environment that stimulates clinical trial professionalism and co-operation, and adherence to national and international ethical, quality and regulatory standards, make Queensland a prime choice for national and international sponsors who are wishing to conduct clinical and pre-clinical trials.